Bringing the fundamentals into focus…
Back to Phreesia, Inc.
How Phreesia, Inc. stacks up
PHR · against 488 other Healthcare companies of similar size
Valuation
53/ 100
Above the middle of the pack.
Ranked #225 of 489 · scores higher than 53% of peers
Bars: peers in each 10-point band of the valuation score42 peers with a valuation score of 50–59, including PHR · Click a bar to see the companies
Why valuation scores 53?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- Earnings yield is close to the peer norm. Earnings yield: 1.5% vs peer median 1.5%
- EBITDA yield is close to the peer norm. EBITDA yield: 6.0% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 92% of peers. Free cash flow yield: 8.9% vs peer median 0.0%
Metric by metric
Position: dot = PHR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PHR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 476 reported | 1.5% | 1.0% | 55% | 30% | |
| EBITDA yieldHigher is better · 495 reported | 6.0% | 3.7% | 61% | 50% | |
| Free cash flow yieldHigher is better · 203 reported | 8.9% | -3.6% | 91% | 20% | |
| Book yieldHigher is better · 485 reported | 49.0% | 44.7% | 55% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around PHRScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score